Call for Papers

Article List

Editorial [Hot topic:Novel Potential Therapeutic Approaches for Schizophrenia (Executive Guest Editor: Kenji Hashimoto)]
[ Vol. 17 , Issue. 2 ]
Author(s): Kenji Hashimoto
Pages: 92-93 (2)
Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
[ Vol. 17 , Issue. 2 ]
Author(s): Shigeyuki Chaki and Hirohiko Hikichi
Pages: 94-102 (9)
Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
[ Vol. 17 , Issue. 2 ]
Author(s): Dana V. Ferraris and Takashi Tsukamoto
Pages: 103-111 (9)
Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia
[ Vol. 17 , Issue. 2 ]
Author(s): Kenji Hashimoto
Pages: 112-120 (9)
α7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia
[ Vol. 17 , Issue. 2 ]
Author(s): Masatomo Ishikawa and Kenji Hashimoto
Pages: 121-129 (9)
Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects
[ Vol. 17 , Issue. 2 ]
Author(s): Norbert Muller, Aye-Mu Myint and Markus J. Schwarz
Pages: 130-136 (7)
PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia
[ Vol. 17 , Issue. 2 ]
Author(s): Jan Kehler and Jacob Nielsen
Pages: 137-150 (14)
Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
[ Vol. 17 , Issue. 2 ]
Author(s): Silvia Paba, Roberto Frau, Sean C. Godar, Paola Devoto, Francesco Marrosu and Marco Bortolato
Pages: 151-167 (17)
Role of Polyunsaturated Fatty Acids and Fatty Acid Binding Protein in the Pathogenesis of Schizophrenia
[ Vol. 17 , Issue. 2 ]
Author(s): Motoko Maekawa, Yuji Owada and Takeo Yoshikawa
Pages: 168-175 (8)
MicroRNAs: A Novel Therapeutic Target for Schizophrenia
[ Vol. 17 , Issue. 2 ]
Author(s): Javier A. Bravo and Timothy G. Dinan
Pages: 176-188 (13)